0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Site-directed Mutagenesis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-16H14571
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Site directed Mutagenesis Service Market Research Report 2023
BUY CHAPTERS

Site-directed Mutagenesis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-16H14571
Report
December 2024
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Site-directed Mutagenesis Service - Market Size

The global market for Site-directed Mutagenesis Service was estimated to be worth US$ 974 million in 2023 and is forecast to a readjusted size of US$ 1353.3 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030

Site-directed Mutagenesis Service - Market

Site-directed Mutagenesis Service - Market

Site-directed mutagenesis is a widely used technique in molecular biology and genetic engineering that allows researchers to introduce specific changes or mutations into a DNA sequence.
Site-directed mutagenesis services are provided by various companies and research institutions to support scientific research, drug development, and other applications requiring precise modifications to DNA sequences. These services often involve the design and synthesis of custom DNA templates with specific mutations or modifications requested by the client.
The market status and future development trends of the site-directed mutagenesis service market include the following:
Increasing Demand: With advancements in genetic research and biotechnology applications, there is a growing demand for site-directed mutagenesis services. Researchers in academia, pharmaceutical companies, and biotech firms rely on these services to create specific genetic variants for functional studies, protein engineering, therapeutic development, and other research purposes.
Customization and Specialization: As the field of genetics becomes more specialized, site-directed mutagenesis service providers may focus on offering tailored solutions to meet the specific needs of different research areas or industries. This could involve expertise in specific organisms, gene families, or targeted genetic modifications.
Automation and High-throughput Capabilities: To improve efficiency and cost-effectiveness, site-directed mutagenesis services may adopt automation and high-throughput technologies. This allows for the simultaneous generation of multiple mutations or modifications in a faster and more streamlined manner.
Quality Assurance and Validation: Given the critical nature of site-directed mutagenesis in research and product development, there is an increasing emphasis on quality control, validation, and rigorous quality assurance measures by service providers. This ensures accurate and reliable results, which are essential for downstream applications.
Integration with Other Services: Site-directed mutagenesis services may be integrated with other molecular biology services or techniques to offer comprehensive solutions. For example, providers may offer sequencing, gene synthesis, or cloning services alongside site-directed mutagenesis to facilitate a seamless workflow for researchers.
Regulatory Compliance: As the applications of site-directed mutagenesis expand into areas like gene therapy or agricultural biotechnology, adherence to regulatory guidelines and ethical considerations will become increasingly important.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Site-directed Mutagenesis Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Site-directed Mutagenesis Service by region & country, by Type, and by Application.
The Site-directed Mutagenesis Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Site-directed Mutagenesis Service.
Market Segmentation

Scope of Site-directed Mutagenesis Service - Market Report

Report Metric Details
Report Name Site-directed Mutagenesis Service - Market
Forecasted market size in 2030 US$ 1353.3 million
CAGR 4.8%
Forecasted years 2024 - 2030
Segment by Type:
  • Standard Site-directed Mutagenesis Service
  • Customized Site-directed Mutagenesis Service
Segment by Application
  • Scientific Research
  • Gene Therapy
  • Cell Therapy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GenScript, Eurofins, Applied Biological Materials, Azenta Life Sciences, Thermo Fisher Scientific, Bon Opus Biosciences, Charles Rive, Creative Biogene, Synbio Technologies, Creative Biolabs, NovoPro, Bionexus, Biotech Desk, NorClone, Eton Bioscience, Syd Labs, Genosphere Biotechnologies, WZ Biosciences, FulenGen, GENEWIZ, iGene Biotechnology, Tsingke, AtaGenix, Zoonbio Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Site-directed Mutagenesis Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Site-directed Mutagenesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Site-directed Mutagenesis Service in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Site-directed Mutagenesis Service - Market size in 2030?

Ans: The Site-directed Mutagenesis Service - Market size in 2030 will be US$ 1353.3 million.

Who are the main players in the Site-directed Mutagenesis Service - Market report?

Ans: The main players in the Site-directed Mutagenesis Service - Market are GenScript, Eurofins, Applied Biological Materials, Azenta Life Sciences, Thermo Fisher Scientific, Bon Opus Biosciences, Charles Rive, Creative Biogene, Synbio Technologies, Creative Biolabs, NovoPro, Bionexus, Biotech Desk, NorClone, Eton Bioscience, Syd Labs, Genosphere Biotechnologies, WZ Biosciences, FulenGen, GENEWIZ, iGene Biotechnology, Tsingke, AtaGenix, Zoonbio Biotechnology

What are the Application segmentation covered in the Site-directed Mutagenesis Service - Market report?

Ans: The Applications covered in the Site-directed Mutagenesis Service - Market report are Scientific Research, Gene Therapy, Cell Therapy, Others

What are the Type segmentation covered in the Site-directed Mutagenesis Service - Market report?

Ans: The Types covered in the Site-directed Mutagenesis Service - Market report are Standard Site-directed Mutagenesis Service, Customized Site-directed Mutagenesis Service

1 Market Overview
1.1 Site-directed Mutagenesis Service Product Introduction
1.2 Global Site-directed Mutagenesis Service Market Size Forecast
1.3 Site-directed Mutagenesis Service Market Trends & Drivers
1.3.1 Site-directed Mutagenesis Service Industry Trends
1.3.2 Site-directed Mutagenesis Service Market Drivers & Opportunity
1.3.3 Site-directed Mutagenesis Service Market Challenges
1.3.4 Site-directed Mutagenesis Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Site-directed Mutagenesis Service Players Revenue Ranking (2023)
2.2 Global Site-directed Mutagenesis Service Revenue by Company (2019-2024)
2.3 Key Companies Site-directed Mutagenesis Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Site-directed Mutagenesis Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Site-directed Mutagenesis Service
2.6 Site-directed Mutagenesis Service Market Competitive Analysis
2.6.1 Site-directed Mutagenesis Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Site-directed Mutagenesis Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Site-directed Mutagenesis Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Standard Site-directed Mutagenesis Service
3.1.2 Customized Site-directed Mutagenesis Service
3.2 Global Site-directed Mutagenesis Service Sales Value by Type
3.2.1 Global Site-directed Mutagenesis Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Site-directed Mutagenesis Service Sales Value, by Type (2019-2030)
3.2.3 Global Site-directed Mutagenesis Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Scientific Research
4.1.2 Gene Therapy
4.1.3 Cell Therapy
4.1.4 Others
4.2 Global Site-directed Mutagenesis Service Sales Value by Application
4.2.1 Global Site-directed Mutagenesis Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Site-directed Mutagenesis Service Sales Value, by Application (2019-2030)
4.2.3 Global Site-directed Mutagenesis Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Site-directed Mutagenesis Service Sales Value by Region
5.1.1 Global Site-directed Mutagenesis Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Site-directed Mutagenesis Service Sales Value by Region (2019-2024)
5.1.3 Global Site-directed Mutagenesis Service Sales Value by Region (2025-2030)
5.1.4 Global Site-directed Mutagenesis Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Site-directed Mutagenesis Service Sales Value, 2019-2030
5.2.2 North America Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Site-directed Mutagenesis Service Sales Value, 2019-2030
5.3.2 Europe Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Site-directed Mutagenesis Service Sales Value, 2019-2030
5.4.2 Asia Pacific Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Site-directed Mutagenesis Service Sales Value, 2019-2030
5.5.2 South America Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Site-directed Mutagenesis Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Site-directed Mutagenesis Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Site-directed Mutagenesis Service Sales Value
6.3 United States
6.3.1 United States Site-directed Mutagenesis Service Sales Value, 2019-2030
6.3.2 United States Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Site-directed Mutagenesis Service Sales Value, 2019-2030
6.4.2 Europe Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Site-directed Mutagenesis Service Sales Value, 2019-2030
6.5.2 China Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Site-directed Mutagenesis Service Sales Value, 2019-2030
6.6.2 Japan Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Site-directed Mutagenesis Service Sales Value, 2019-2030
6.7.2 South Korea Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Site-directed Mutagenesis Service Sales Value, 2019-2030
6.8.2 Southeast Asia Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Site-directed Mutagenesis Service Sales Value, 2019-2030
6.9.2 India Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Site-directed Mutagenesis Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GenScript
7.1.1 GenScript Profile
7.1.2 GenScript Main Business
7.1.3 GenScript Site-directed Mutagenesis Service Products, Services and Solutions
7.1.4 GenScript Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.1.5 GenScript Recent Developments
7.2 Eurofins
7.2.1 Eurofins Profile
7.2.2 Eurofins Main Business
7.2.3 Eurofins Site-directed Mutagenesis Service Products, Services and Solutions
7.2.4 Eurofins Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.2.5 Eurofins Recent Developments
7.3 Applied Biological Materials
7.3.1 Applied Biological Materials Profile
7.3.2 Applied Biological Materials Main Business
7.3.3 Applied Biological Materials Site-directed Mutagenesis Service Products, Services and Solutions
7.3.4 Applied Biological Materials Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.3.5 Azenta Life Sciences Recent Developments
7.4 Azenta Life Sciences
7.4.1 Azenta Life Sciences Profile
7.4.2 Azenta Life Sciences Main Business
7.4.3 Azenta Life Sciences Site-directed Mutagenesis Service Products, Services and Solutions
7.4.4 Azenta Life Sciences Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.4.5 Azenta Life Sciences Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
7.6 Bon Opus Biosciences
7.6.1 Bon Opus Biosciences Profile
7.6.2 Bon Opus Biosciences Main Business
7.6.3 Bon Opus Biosciences Site-directed Mutagenesis Service Products, Services and Solutions
7.6.4 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.6.5 Bon Opus Biosciences Recent Developments
7.7 Charles Rive
7.7.1 Charles Rive Profile
7.7.2 Charles Rive Main Business
7.7.3 Charles Rive Site-directed Mutagenesis Service Products, Services and Solutions
7.7.4 Charles Rive Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.7.5 Charles Rive Recent Developments
7.8 Creative Biogene
7.8.1 Creative Biogene Profile
7.8.2 Creative Biogene Main Business
7.8.3 Creative Biogene Site-directed Mutagenesis Service Products, Services and Solutions
7.8.4 Creative Biogene Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.8.5 Creative Biogene Recent Developments
7.9 Synbio Technologies
7.9.1 Synbio Technologies Profile
7.9.2 Synbio Technologies Main Business
7.9.3 Synbio Technologies Site-directed Mutagenesis Service Products, Services and Solutions
7.9.4 Synbio Technologies Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.9.5 Synbio Technologies Recent Developments
7.10 Creative Biolabs
7.10.1 Creative Biolabs Profile
7.10.2 Creative Biolabs Main Business
7.10.3 Creative Biolabs Site-directed Mutagenesis Service Products, Services and Solutions
7.10.4 Creative Biolabs Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.10.5 Creative Biolabs Recent Developments
7.11 NovoPro
7.11.1 NovoPro Profile
7.11.2 NovoPro Main Business
7.11.3 NovoPro Site-directed Mutagenesis Service Products, Services and Solutions
7.11.4 NovoPro Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.11.5 NovoPro Recent Developments
7.12 Bionexus
7.12.1 Bionexus Profile
7.12.2 Bionexus Main Business
7.12.3 Bionexus Site-directed Mutagenesis Service Products, Services and Solutions
7.12.4 Bionexus Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.12.5 Bionexus Recent Developments
7.13 Biotech Desk
7.13.1 Biotech Desk Profile
7.13.2 Biotech Desk Main Business
7.13.3 Biotech Desk Site-directed Mutagenesis Service Products, Services and Solutions
7.13.4 Biotech Desk Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.13.5 Biotech Desk Recent Developments
7.14 NorClone
7.14.1 NorClone Profile
7.14.2 NorClone Main Business
7.14.3 NorClone Site-directed Mutagenesis Service Products, Services and Solutions
7.14.4 NorClone Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.14.5 NorClone Recent Developments
7.15 Eton Bioscience
7.15.1 Eton Bioscience Profile
7.15.2 Eton Bioscience Main Business
7.15.3 Eton Bioscience Site-directed Mutagenesis Service Products, Services and Solutions
7.15.4 Eton Bioscience Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.15.5 Eton Bioscience Recent Developments
7.16 Syd Labs
7.16.1 Syd Labs Profile
7.16.2 Syd Labs Main Business
7.16.3 Syd Labs Site-directed Mutagenesis Service Products, Services and Solutions
7.16.4 Syd Labs Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.16.5 Syd Labs Recent Developments
7.17 Genosphere Biotechnologies
7.17.1 Genosphere Biotechnologies Profile
7.17.2 Genosphere Biotechnologies Main Business
7.17.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Products, Services and Solutions
7.17.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.17.5 Genosphere Biotechnologies Recent Developments
7.18 WZ Biosciences
7.18.1 WZ Biosciences Profile
7.18.2 WZ Biosciences Main Business
7.18.3 WZ Biosciences Site-directed Mutagenesis Service Products, Services and Solutions
7.18.4 WZ Biosciences Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.18.5 WZ Biosciences Recent Developments
7.19 FulenGen
7.19.1 FulenGen Profile
7.19.2 FulenGen Main Business
7.19.3 FulenGen Site-directed Mutagenesis Service Products, Services and Solutions
7.19.4 FulenGen Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.19.5 FulenGen Recent Developments
7.20 GENEWIZ
7.20.1 GENEWIZ Profile
7.20.2 GENEWIZ Main Business
7.20.3 GENEWIZ Site-directed Mutagenesis Service Products, Services and Solutions
7.20.4 GENEWIZ Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.20.5 GENEWIZ Recent Developments
7.21 iGene Biotechnology
7.21.1 iGene Biotechnology Profile
7.21.2 iGene Biotechnology Main Business
7.21.3 iGene Biotechnology Site-directed Mutagenesis Service Products, Services and Solutions
7.21.4 iGene Biotechnology Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.21.5 iGene Biotechnology Recent Developments
7.22 Tsingke
7.22.1 Tsingke Profile
7.22.2 Tsingke Main Business
7.22.3 Tsingke Site-directed Mutagenesis Service Products, Services and Solutions
7.22.4 Tsingke Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.22.5 Tsingke Recent Developments
7.23 AtaGenix
7.23.1 AtaGenix Profile
7.23.2 AtaGenix Main Business
7.23.3 AtaGenix Site-directed Mutagenesis Service Products, Services and Solutions
7.23.4 AtaGenix Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.23.5 AtaGenix Recent Developments
7.24 Zoonbio Biotechnology
7.24.1 Zoonbio Biotechnology Profile
7.24.2 Zoonbio Biotechnology Main Business
7.24.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Products, Services and Solutions
7.24.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue (US$ Million) & (2019-2024)
7.24.5 Zoonbio Biotechnology Recent Developments
8 Industry Chain Analysis
8.1 Site-directed Mutagenesis Service Industrial Chain
8.2 Site-directed Mutagenesis Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Site-directed Mutagenesis Service Sales Model
8.5.2 Sales Channel
8.5.3 Site-directed Mutagenesis Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Site-directed Mutagenesis Service Market Trends
    Table 2. Site-directed Mutagenesis Service Market Drivers & Opportunity
    Table 3. Site-directed Mutagenesis Service Market Challenges
    Table 4. Site-directed Mutagenesis Service Market Restraints
    Table 5. Global Site-directed Mutagenesis Service Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Site-directed Mutagenesis Service Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Site-directed Mutagenesis Service Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Site-directed Mutagenesis Service Product Type
    Table 9. Key Companies Time to Begin Mass Production of Site-directed Mutagenesis Service
    Table 10. Global Site-directed Mutagenesis Service Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Site-directed Mutagenesis Service as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Site-directed Mutagenesis Service Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Site-directed Mutagenesis Service Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Site-directed Mutagenesis Service Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Site-directed Mutagenesis Service Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Site-directed Mutagenesis Service Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Site-directed Mutagenesis Service Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Site-directed Mutagenesis Service Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Site-directed Mutagenesis Service Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Site-directed Mutagenesis Service Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Site-directed Mutagenesis Service Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Site-directed Mutagenesis Service Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Site-directed Mutagenesis Service Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Site-directed Mutagenesis Service Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Site-directed Mutagenesis Service Sales Value by Region (2019-2024) & (%)
    Table 27. Global Site-directed Mutagenesis Service Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Site-directed Mutagenesis Service Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Site-directed Mutagenesis Service Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Site-directed Mutagenesis Service Sales Value, (2025-2030) & (US$ Million)
    Table 31. GenScript Basic Information List
    Table 32. GenScript Description and Business Overview
    Table 33. GenScript Site-directed Mutagenesis Service Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of GenScript (2019-2024)
    Table 35. GenScript Recent Developments
    Table 36. Eurofins Basic Information List
    Table 37. Eurofins Description and Business Overview
    Table 38. Eurofins Site-directed Mutagenesis Service Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Eurofins (2019-2024)
    Table 40. Eurofins Recent Developments
    Table 41. Applied Biological Materials Basic Information List
    Table 42. Applied Biological Materials Description and Business Overview
    Table 43. Applied Biological Materials Site-directed Mutagenesis Service Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Applied Biological Materials (2019-2024)
    Table 45. Applied Biological Materials Recent Developments
    Table 46. Azenta Life Sciences Basic Information List
    Table 47. Azenta Life Sciences Description and Business Overview
    Table 48. Azenta Life Sciences Site-directed Mutagenesis Service Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Azenta Life Sciences (2019-2024)
    Table 50. Azenta Life Sciences Recent Developments
    Table 51. Thermo Fisher Scientific Basic Information List
    Table 52. Thermo Fisher Scientific Description and Business Overview
    Table 53. Thermo Fisher Scientific Site-directed Mutagenesis Service Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Thermo Fisher Scientific (2019-2024)
    Table 55. Thermo Fisher Scientific Recent Developments
    Table 56. Bon Opus Biosciences Basic Information List
    Table 57. Bon Opus Biosciences Description and Business Overview
    Table 58. Bon Opus Biosciences Site-directed Mutagenesis Service Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Bon Opus Biosciences (2019-2024)
    Table 60. Bon Opus Biosciences Recent Developments
    Table 61. Charles Rive Basic Information List
    Table 62. Charles Rive Description and Business Overview
    Table 63. Charles Rive Site-directed Mutagenesis Service Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Charles Rive (2019-2024)
    Table 65. Charles Rive Recent Developments
    Table 66. Creative Biogene Basic Information List
    Table 67. Creative Biogene Description and Business Overview
    Table 68. Creative Biogene Site-directed Mutagenesis Service Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Creative Biogene (2019-2024)
    Table 70. Creative Biogene Recent Developments
    Table 71. Synbio Technologies Basic Information List
    Table 72. Synbio Technologies Description and Business Overview
    Table 73. Synbio Technologies Site-directed Mutagenesis Service Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Synbio Technologies (2019-2024)
    Table 75. Synbio Technologies Recent Developments
    Table 76. Creative Biolabs Basic Information List
    Table 77. Creative Biolabs Description and Business Overview
    Table 78. Creative Biolabs Site-directed Mutagenesis Service Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Creative Biolabs (2019-2024)
    Table 80. Creative Biolabs Recent Developments
    Table 81. NovoPro Basic Information List
    Table 82. NovoPro Description and Business Overview
    Table 83. NovoPro Site-directed Mutagenesis Service Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of NovoPro (2019-2024)
    Table 85. NovoPro Recent Developments
    Table 86. Bionexus Basic Information List
    Table 87. Bionexus Description and Business Overview
    Table 88. Bionexus Site-directed Mutagenesis Service Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Bionexus (2019-2024)
    Table 90. Bionexus Recent Developments
    Table 91. Biotech Desk Basic Information List
    Table 92. Biotech Desk Description and Business Overview
    Table 93. Biotech Desk Site-directed Mutagenesis Service Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Biotech Desk (2019-2024)
    Table 95. Biotech Desk Recent Developments
    Table 96. NorClone Basic Information List
    Table 97. NorClone Description and Business Overview
    Table 98. NorClone Site-directed Mutagenesis Service Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of NorClone (2019-2024)
    Table 100. NorClone Recent Developments
    Table 101. Eton Bioscience Basic Information List
    Table 102. Eton Bioscience Description and Business Overview
    Table 103. Eton Bioscience Site-directed Mutagenesis Service Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Eton Bioscience (2019-2024)
    Table 105. Eton Bioscience Recent Developments
    Table 106. Syd Labs Basic Information List
    Table 107. Syd Labs Description and Business Overview
    Table 108. Syd Labs Site-directed Mutagenesis Service Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Syd Labs (2019-2024)
    Table 110. Syd Labs Recent Developments
    Table 111. Genosphere Biotechnologies Basic Information List
    Table 112. Genosphere Biotechnologies Description and Business Overview
    Table 113. Genosphere Biotechnologies Site-directed Mutagenesis Service Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Genosphere Biotechnologies (2019-2024)
    Table 115. Genosphere Biotechnologies Recent Developments
    Table 116. WZ Biosciences Basic Information List
    Table 117. WZ Biosciences Description and Business Overview
    Table 118. WZ Biosciences Site-directed Mutagenesis Service Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of WZ Biosciences (2019-2024)
    Table 120. WZ Biosciences Recent Developments
    Table 121. FulenGen Basic Information List
    Table 122. FulenGen Description and Business Overview
    Table 123. FulenGen Site-directed Mutagenesis Service Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of FulenGen (2019-2024)
    Table 125. FulenGen Recent Developments
    Table 126. GENEWIZ Basic Information List
    Table 127. GENEWIZ Description and Business Overview
    Table 128. GENEWIZ Site-directed Mutagenesis Service Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of GENEWIZ (2019-2024)
    Table 130. GENEWIZ Recent Developments
    Table 131. iGene Biotechnology Basic Information List
    Table 132. iGene Biotechnology Description and Business Overview
    Table 133. iGene Biotechnology Site-directed Mutagenesis Service Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of iGene Biotechnology (2019-2024)
    Table 135. iGene Biotechnology Recent Developments
    Table 136. Tsingke Basic Information List
    Table 137. Tsingke Description and Business Overview
    Table 138. Tsingke Site-directed Mutagenesis Service Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Tsingke (2019-2024)
    Table 140. Tsingke Recent Developments
    Table 141. AtaGenix Basic Information List
    Table 142. AtaGenix Description and Business Overview
    Table 143. AtaGenix Site-directed Mutagenesis Service Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of AtaGenix (2019-2024)
    Table 145. AtaGenix Recent Developments
    Table 146. Zoonbio Biotechnology Basic Information List
    Table 147. Zoonbio Biotechnology Description and Business Overview
    Table 148. Zoonbio Biotechnology Site-directed Mutagenesis Service Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Site-directed Mutagenesis Service Business of Zoonbio Biotechnology (2019-2024)
    Table 150. Zoonbio Biotechnology Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Site-directed Mutagenesis Service Downstream Customers
    Table 154. Site-directed Mutagenesis Service Distributors List
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
    Table 158. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Site-directed Mutagenesis Service Product Picture
    Figure 2. Global Site-directed Mutagenesis Service Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Site-directed Mutagenesis Service Sales Value (2019-2030) & (US$ Million)
    Figure 4. Site-directed Mutagenesis Service Report Years Considered
    Figure 5. Global Site-directed Mutagenesis Service Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Site-directed Mutagenesis Service Revenue in 2023
    Figure 7. Site-directed Mutagenesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Standard Site-directed Mutagenesis Service Picture
    Figure 9. Customized Site-directed Mutagenesis Service Picture
    Figure 10. Global Site-directed Mutagenesis Service Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Site-directed Mutagenesis Service Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Scientific Research
    Figure 13. Product Picture of Gene Therapy
    Figure 14. Product Picture of Cell Therapy
    Figure 15. Product Picture of Others
    Figure 16. Global Site-directed Mutagenesis Service Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Site-directed Mutagenesis Service Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Site-directed Mutagenesis Service Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Site-directed Mutagenesis Service Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Site-directed Mutagenesis Service Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Site-directed Mutagenesis Service Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Site-directed Mutagenesis Service Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Site-directed Mutagenesis Service Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Site-directed Mutagenesis Service Sales Value (%), (2019-2030)
    Figure 29. United States Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Site-directed Mutagenesis Service Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Site-directed Mutagenesis Service Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Site-directed Mutagenesis Service Sales Value by Application (%), 2023 VS 2030
    Figure 50. Site-directed Mutagenesis Service Industrial Chain
    Figure 51. Site-directed Mutagenesis Service Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS